In the promptly evolving field of most cancers therapeutics, understanding the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is critical for producing efficient remedies. Among the most promising strategies is the use of in vitro bystander outcome assays, which Engage in a pivotal role in enhancing therapeutic efficacy. These assays, supp